Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperpyrexia, allergic-type response and death occurring with low-dose bleomycin administration.

R L Levy, S Chiarillo

    Oncology
    |January 1, 1980
    PubMed
    Summary

    A patient died from a severe reaction to a low bleomycin dose, even with premedication. Researchers recommend routine use of 1 unit or lower bleomycin test doses due to unknown safety thresholds.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Juvenile cataract in association with tuberous sclerosis complex.

    Ophthalmic genetics·2020
    Same author

    Conducting multinational, cross-cultural research in the functional gastrointestinal disorders: issues and recommendations. A Rome Foundation working team report.

    Alimentary pharmacology & therapeutics·2014
    Same author

    Obesity does not affect sodium picosulphate bowel preparation.

    Internal medicine journal·2012
    Same author

    Facts on Coronary Artery Disease, Based on a Survey of the Clinical and Pathological Records of 762 Cases: Abstract.

    Transactions of the American Clinical and Climatological Association·2011
    Same author

    Sudden Death in Patients with Coronary Sclerosis and Thrombosis.

    Transactions of the American Clinical and Climatological Association·2011
    Same author

    Electrocardiographic Changes Caused by Induced Anoxemia in Normal Persons and in Patients with Disease of the Coronary Arteries.

    Transactions of the American Clinical and Climatological Association·2011

    Area of Science:

    • Oncology
    • Pharmacology

    Background:

    • Bleomycin is an antineoplastic agent used in cancer treatment.
    • Severe reactions, including fatalities, have been reported with bleomycin administration.
    • The safe initial test dose and efficacy of premedication for bleomycin are not well-established.

    Observation:

    • A case report details a fatal reaction (hyperpyrexia, shock, death) after a low initial dose (7.5 units) of bleomycin for metastatic carcinoma.
    • Premedication with high-dose dexamethasone and acetaminophen failed to prevent the severe reaction.
    • Literature review revealed a nearly fatal reaction to a 1-unit test dose and prior fatal cases in lymphoma patients receiving higher initial doses (≥25 units/m2).

    Findings:

    • Fatal bleomycin reactions can occur even with low initial doses, challenging previous dose-response assumptions.

    Related Experiment Videos

  • Standard premedication protocols may not be sufficient to prevent severe bleomycin-induced toxicity.
  • The safe and effective test dose for bleomycin remains undetermined.

    • Implications:

    • Routine administration of very low bleomycin test doses (≤1 unit) is suggested to mitigate risks.
    • Further research is needed to clarify the role and efficacy of premedication in preventing bleomycin hypersensitivity.
    • This case highlights the unpredictable and potentially severe nature of bleomycin reactions, necessitating cautious dosing and monitoring.